Strategic Solutions Case Studies
Explore our expertise and success stories.
Learn more about our FSP and blended models in our library of case studies.
Our team of operational, functional and therapeutic specialists offer a range of FSP and blended solutions that can be customised to deliver the most efficient operating model for your organisation.
.jpg?crop=yes&w=1979&h=1041&a=0,140&itok=EtR-PRLN "Boardroom Meeting (14)"){kind=icon}
FSP for a mid-sized device company
A mid-sized medical device company, required a smooth transition from using a staffing company alongside a full-service model, to an FSP model.
Driving high quality in global clinical drug development
A China-based biotech required an FSP model to grow team to 130 resources and increase retention to 85% in a highly competitive market.
Elevating Biopharma R&D
A biopharma partner required support with an FSP model across multiple service areas, seamlessly integrated with an existing FSO partnership.
Transforming a partnership into a blended model
A 10-year existing FSO partnership was expanded to incorporate a blended model to aid sourcing niche roles across multiple geographies whilst the sponsor maintained greater control of key areas.
Transformation in a 20-year partnership
Explore the implementation of a dedicated business unit within a 20-year large pharma partnership to facilitate a truly blended solution.
Partnership model evolutions for Top 10 pharma partner
A customised blended model has benefitted a top 10 pharma partner as their organisation has evolved over 13 years.
Chinese sponsor adopts blended delivery model
A Chinese sponsor adopts a blended delivery model to realise cost savings and assume greater autonomy.
Strategic blended solution across multiple services for global upscale
A large pharma partner required a blended solutions to support significant upscale across clinical operations, pharmacovigilance and data science.
Blended solution gives emerging pharma greater control with expert support
When a mid-sized biopharmaceutical company was planning pivotal trials for a drug in a rare disease area, it sought
a more transparent, more reliable operating mode.
a more transparent, more reliable operating mode.